Johannes Schildt
Angel Investor
Stockholm, Sweden
Johannes Schildt is a seed investor in Stockholm focused on Health Care and Software. Johannes Schildt, a true serial entrepreneur who founded or co-founded more than 3 companies, started his first company while still in school. Schildt later made a meteoric career at Stardoll working alongside people like Henrik Torstensson & Marcus Gners. Johannes successfully launched Stardoll's first official Facebook game, reaching1,000,000 monthly unique users within 3 months after launch. Today, Johannes is the CEO & Co-founder of Kry. By combining new technology with leading medical expertise KRY has built a platform to make healthcare digital.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Johannes Schildt invests in
Stages Johannes Schildt invests in
Countries Johannes Schildt invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.8M–$4.4M
- Pre-Seed
- $641k–$4M
- Series A
- $17M–$18M
Investment Focus
Industry
- Health Care 6 (43%)
- Software 4 (29%)
- Artificial Intelligence 4 (29%)
- Machine Learning 2 (14%)
- Information Technology 2 (14%)
Stage
- Seed 7 (50%)
- Pre-Seed 4 (29%)
- Series A 2 (14%)
- Angel 1 (7%)
Country
- Sweden 5 (36%)
- Finland 4 (29%)
- United States 2 (14%)
- Denmark 1 (7%)
- Switzerland 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| is building a video-first hiring platform that combines AI interview agents with short-form video profiles. | $4M / Pre-Seed / Jun 23, 2026 | ||
| Noru builds an AI-native platform for regulatory compliance. | $640.6K / Pre-Seed / Mar 18, 2026 | ||
| Cerrion is a visual AI that helps production teams react faster to process deviations, automate root cause analysis, and implement targeted improvement actions. They believe that process transparency enabled by AI and computer vision is key to achieving more autonomy and sustainability in manufacturing. Their software is built and designed withproduction teams from all over the world in the loop. | $18M / Series A / Nov 24, 2025 | ||
| Volter software offers a comprehensive solution for commercial and industrial property owners to deploy, manage, and improve solar assets. | $3.2M / Pre-Seed / Nov 28, 2024 | ||
| Vital API allows developers to access health data from wearable devices and at-home test kits. The company was founded in 2021 by Maitham Dib and is headquartered in San Francisco, California, United States. | $2.9M / Seed / Jun 03, 2022 | ||
| Helppy is redefining elderly care. We are the trusted companion of seniors and their families. Helppy is a personalized elderly care platform supported by technology. We provide personal care, family support and a broad range of additional services to elderly at home. | $3.3M / Seed / May 17, 2022 | ||
| Hemby is Europe’s first on-demand like elderly home care service. Get personally-dedicated carers in hours, not days. Made possible by our own end-to-end technology platform. We operate in Germany and Finland. We’re backed by leading Nordic VC funds Alliance and Icebreaker as well as three superstar angels, whom all founded their own unicorns,namely: Johannes Schildt (Co-Founder & CEO of KRY), Elias Aalto (Co-Founder of Wolt), Ilkka Paananen via Family Office Illusian (Co-Founder of Supercell) and Yury Yakubchyk (Founder & CEO of Elemy). In the future, care will be on-demand, and personal. Follow us and join our team!www.hemby.com/en www.hemby.de www.hemby.fi www.hemby.co.uk | $3.2M / Seed / May 17, 2022 | ||
| Valar Labs makes AI to interpret solid tumors and deliver insights, so physicians and patients can make informed treatment decisions. Their AI algorithms analyze digitized pathology slides to assess spatial features, and they design transparent systems grounded in underlying biology so physicians can trust the results. | $4M / Seed / Mar 30, 2022 | ||
| Depict.ai is building a product recommendation engine to help bring “Amazon-quality” product recommendation for any e-commerce store. | $17M / Series A / Feb 24, 2022 | ||
| Infrastructure for building production-grade analytical AI agents inside your data product. | $4.4M / Seed / Nov 26, 2021 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Johannes Schildt invest in?
Johannes Schildt invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 14 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Johannes Schildt's check size?
Johannes Schildt typically joins rounds of $2.8M–$4.4M at Seed, $641k–$4M at Pre-Seed and $17M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Johannes Schildt participates in.
How do I contact Johannes Schildt?
Public channels for Johannes Schildt include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Johannes Schildt last invest?
The most recent investment recorded for Johannes Schildt closed in Jun 2026. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
